Company record

Restate

Restate provides durable execution infrastructure for building reliable modern applications, from distributed backends to AI agents. restate.dev

Funding

Of the 90 Series A rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, Restate's $20 million is the joint 47th largest; their median is $20.85 million.

Whether AI names Restate

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

Related records

Closest rounds in the roster for September 28, 2026 – October 3, 2026: OuterSignal ($22 million Series A, September 30, 2026), Ascerta ($18 million Series A, September 30, 2026), IPercept ($16.5 million Series A, September 29, 2026), Daptic ($15 million Series A, October 1, 2026), Halluminate ($30 million Series A, October 1, 2026), Atomic ($12.5 million Series A, September 29, 2026).

Singular, which led this round, also led Orakl Oncology ($34 million Series A, November 12, 2026) and Sumary ($25m Seed, November 9, 2026).

Capital One Ventures, named as an investor in this round, led Sentra ($150 million Series C, November 4, 2026). It is also named as an investor in Overwatch Data ($15 million Series A, October 26, 2026).

Sources

Every fact on this page links its source. Corrections need a public source: see Contact.